Dermata to Participate in the Gilmartin Group Emerging Growth Company Showcase

Author's Avatar
Aug 25, 2022

SAN DIEGO, CA / ACCESSWIRE / August 24, 2022 / Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata," or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced that Dermata will participate in the Gilmartin Group Emerging Growth Company Showcase, being held on August 31, 2022.